In a large randomized trial of statin therapy in patients of South-Asian origin with
hypercholesterolemia, 740 patients in the United States and Canada received 6 weeks of …

Aim To determine whether a compliance-enhancing program could increase the level of
lipid control in patients treated with rosuvastatin. Methods and results A total of 8108 patients …

More is spent in the US on rosuvastatin than any other statin. Yet the evidence of its health
benefits has always been weak and there is growing evidence of harmful side effects …

On the basis of large randomized clinical trials, pharmacological antagonists of HMG-CoA
reductase (statins) have become increasingly used in clinical practice for the prevention of …

Rosuvastatin is a novel statin that has been shown to produce large dose-dependent
reductions in low-density lipoprotein cholesterol (LDL-C) in Western hypercholesterolemic …

Despite the importance of reducing cardiovascular disease (CVD) risk, detailed in
guidelines in many countries, repeated surveys show poor physician performance in …

Rosuvastatin is the latest and most potent statin currently on the market. It has the greatest
efficacy compared with all other available statins on total cholesterol and low-density …

The lipid-lowering effects of rosuvastatin and atorvastatin were determined across their dose
ranges in a 6-week, randomized, double-blind trial. Three hundred seventy-four …

OBJECTIVE: To review the currently available information on rosuvastatin in the treatment of
primary hypercholesterolemia. DATA SOURCES: MEDLEY (2000–January 2001), MEDLIT …

Abstract Objective The Use of Rosuvastatin versus Atorvastatin iN type 2 diabetes mellitUS
(URANUS) study compared rosuvastatin with atorvastatin for the reduction of low-density …